Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medinet Co's EBIT per Share for the
three
months ended in Mar. 2026 was 円-1.05.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円-4.80.
During the past 3 years, the average EBIT per Share Growth Rate was 6.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 4.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 14.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medinet Co's EBIT per Share or its related term are showing as below:
TSE:2370'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55.5 Med: 2.75 Max: 36
Current: 6.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Medinet Co was 36.00% per year. The lowest was -55.50% per year. And the median was 2.75% per year.
TSE:2370's 3-Year EBIT Growth Rate is ranked worse than 62.32% of 1173
companies
in the Biotechnology industry
Industry Median: 15.5
vs TSE:2370: 6.70
Medinet Co's EBIT for the
three
months ended in Mar. 2026 was 円-291.7 Mil.
Medinet Co (TSE:2370) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medinet Co EBIT per Share Related Terms
Medinet Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Medinet Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-4.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co (TSE:2370) has a EBIT per Share of 円-4.80 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medinet Co and its competitors. According to the industry distribution chart, Medinet Co ranks #731 out of 1173 companies in the Biotechnology industry, placing it in the top 62.3%.
Is Medinet Co's EBIT per Share too high?
Medinet Co's current EBIT per Share is 円-4.80. Based on the distribution chart, Medinet Co ranks #731 out of 1173 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Medinet Co has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #731 out of 1173 companies for EBIT per Share. This places Medinet Co in the lower half of its industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.50, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medinet Co and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinet Co's current EBIT per Share is 円-4.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.73, compared to a current price of 円24.00 — trading 42.5% below its estimated fair value. The current EBIT per Share is 円-4.80. Medinet Co's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current EBIT per Share is 円-4.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円24.00 is trading 42.5% below its estimated GF Value™ of 円41.73.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
EBIT per Share: 円-4.80
GF Value™: 円41.73 vs. price of 円24.00 (42.5% below fair value)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
45GF Score
Get the complete analysis for TSE:2370
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
